In a recent study on adults living with type 1 diabetes, European researchers assessed the impact of using flash glucose monitoring technology compared to those using only capillary glucose monitoring (finger prick testing) and if that effected time spent in hypoglycaemia.
The study involved 163 adults living with type 1 diabetes from 23 diabetes centres across Europe who were all using multiple daily injection (MDI) insulin therapy to manage their diabetes. These participants, who all had well managed BGLs and were all finger pricking more than 3 times per day, were randomised to intervention (flash monitoring) and control (finger prick testing) groups.
For adults with type 1 diabetes who self-inject daily insulin requirements, frequent monitoring of glucose levels is critical to managing blood glucose levels and reducing the frequency of hypoglycaemia.
Flash glucose monitoring is a technology where you get a glucose level and glucose trends by scanning over a sensor that is inserted under the skin. This sensor is reading the glucose levels in the interstitial fluid, the fluid in-between cells.
Results of the study showed that the T1 participants in the intervention group using flash glucose monitoring had a significant reduction in hypoglycaemic time compared to those using finger prick testing only. The intervention group also displayed an improved level of treatment satisfaction.
Given that the study group all had well managed BGLs to start with and still showed a reduced time in hypoglycaemia by switching to flash monitoring, it can be surmised that for other T1D who find it difficult to finger prick more than 3 times a day and who may not manage BGLs as well as the study group – they would have an even better result by switching to flash monitoring and their time in hypoglycaemia would reduce even more than the study group.
Read more on the study here. https://pubmed.ncbi.nlm.nih.gov/29273897/